577 related articles for article (PubMed ID: 26974250)
1. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
[TBL] [Abstract][Full Text] [Related]
2. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
[TBL] [Abstract][Full Text] [Related]
3. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
4. HPV vaccination: are we initiating too late?
Hofstetter AM; Stockwell MS; Al-Husayni N; Ompad D; Natarajan K; Rosenthal SL; Soren K
Vaccine; 2014 Apr; 32(17):1939-45. PubMed ID: 24530404
[TBL] [Abstract][Full Text] [Related]
5. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.
Kim J; Bell C; Sun M; Kliewer G; Xu L; McInerney M; Svenson LW; Yang H
CMAJ; 2016 Sep; 188(12):E281-E288. PubMed ID: 27378467
[TBL] [Abstract][Full Text] [Related]
6. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
[TBL] [Abstract][Full Text] [Related]
7. Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination.
Teoh D; Nam G; Aase DA; Russell R; Melton GB; Kulasingam S; Vogel RI
JAMA Netw Open; 2022 May; 5(5):e2214020. PubMed ID: 35612854
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
Rodriguez AM; Zeybek B; Vaughn M; Westra J; Kaul S; Montealegre JR; Lin YL; Kuo YF
Cancer; 2020 Apr; 126(8):1656-1667. PubMed ID: 32037524
[TBL] [Abstract][Full Text] [Related]
9. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
10. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Huh WK; Joura EA; Giuliano AR; Iversen OE; de Andrade RP; Ault KA; Bartholomew D; Cestero RM; Fedrizzi EN; Hirschberg AL; Mayrand MH; Ruiz-Sternberg AM; Stapleton JT; Wiley DJ; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Cuzick J; Garland SM; Kjaer SK; Bautista OM; Haupt R; Moeller E; Ritter M; Roberts CC; Shields C; Luxembourg A
Lancet; 2017 Nov; 390(10108):2143-2159. PubMed ID: 28886907
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccination and cervical cytology in young minority women.
Brogly SB; Perkins RB; Zepf D; Longtine J; Yang S
Sex Transm Dis; 2014 Aug; 41(8):511-4. PubMed ID: 25013981
[TBL] [Abstract][Full Text] [Related]
12. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.
Sankaranarayanan R; Joshi S; Muwonge R; Esmy PO; Basu P; Prabhu P; Bhatla N; Nene BM; Shaw J; Poli URR; Verma Y; Zomawia E; Pimple S; Tommasino M; Pawlita M; Gheit T; Waterboer T; Sehr P; Pillai MR;
Vaccine; 2018 Aug; 36(32 Pt A):4783-4791. PubMed ID: 29551226
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada.
Mahmud SM; Kliewer EV; Lambert P; Bozat-Emre S; Demers AA
J Clin Oncol; 2014 Feb; 32(5):438-43. PubMed ID: 24395857
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
15. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
Herweijer E; Sundström K; Ploner A; Uhnoo I; Sparén P; Arnheim-Dahlström L
Int J Cancer; 2016 Jun; 138(12):2867-74. PubMed ID: 26856527
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of school-based and high-risk human papillomavirus vaccination programs against cervical dysplasia in Manitoba, Canada.
Righolt CH; Bozat-Emre S; Mahmud SM
Int J Cancer; 2019 Aug; 145(3):671-677. PubMed ID: 30653261
[TBL] [Abstract][Full Text] [Related]
17. Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine.
Schlecht NF; Masika M; Diaz A; Nucci-Sack A; Salandy A; Pickering S; Strickler HD; Shankar V; Burk RD
JAMA Netw Open; 2019 Oct; 2(10):e1914031. PubMed ID: 31651968
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.
Saeki Y; Saito M; Irie T; Itoh F; Enatsu A; Komura H; Fujii M; Fujii R; Hidaka N; Maehama T; Shirasu N; Waseda T; Shibata T; Takada E; Mibe K; Sakamoto J; Yamada S; Takakura M; Sasagawa T
J Med Virol; 2024 Feb; 96(2):e29413. PubMed ID: 38314927
[TBL] [Abstract][Full Text] [Related]
19. Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015-2017.
Lewis RM; Naleway AL; Klein NP; Crane B; Hsiao A; Aukes L; Timbol J; Querec TD; Steinau M; Weinmann S; Unger ER; Markowitz LE
J Low Genit Tract Dis; 2022 Apr; 26(2):135-139. PubMed ID: 35316258
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study.
Acuti Martellucci C; Nomura S; Yoneoka D; Ueda P; Brotherton J; Canfell K; Palmer M; Manzoli L; Giorgi Rossi P; De Togni A; Palmonari C; Califano A; Saito E; Hashizume M; Shibuya K
BJOG; 2021 Feb; 128(3):532-539. PubMed ID: 32779381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
